These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 25629613

  • 1. Serial measurements of N-terminal pro-brain natriuretic peptide in patients with coronary heart disease.
    Dallmeier D, Pencina MJ, Rajman I, Koenig W, Rothenbacher D, Brenner H.
    PLoS One; 2015; 10(1):e0117143. PubMed ID: 25629613
    [Abstract] [Full Text] [Related]

  • 2. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA.
    JAMA; 2007 Jan 10; 297(2):169-76. PubMed ID: 17213400
    [Abstract] [Full Text] [Related]

  • 3. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.
    JAMA; 2005 Apr 06; 293(13):1609-16. PubMed ID: 15811980
    [Abstract] [Full Text] [Related]

  • 4. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.
    Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, Breteler MM, Witteman JC, van den Meiracker AH.
    Hypertension; 2010 Mar 06; 55(3):785-91. PubMed ID: 20083731
    [Abstract] [Full Text] [Related]

  • 5. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH, Arpegård J, Ostergren J, Svensson P.
    Am J Hypertens; 2014 Mar 06; 27(3):363-71. PubMed ID: 24470529
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.
    Karakas M, Jaensch A, Breitling LP, Brenner H, Koenig W, Rothenbacher D.
    Clin Chem; 2014 Nov 06; 60(11):1441-9. PubMed ID: 25139456
    [Abstract] [Full Text] [Related]

  • 7. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M, Clodi M, Vila G, Luger A, Neuhold S, Wurm R, Adlbrecht C, Strunk G, Fritzer-Szekeres M, Prager R, Pacher R, Hülsmann M.
    Heart; 2016 Dec 15; 102(24):1963-1968. PubMed ID: 27456261
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
    Ranjith N, Pegoraro RJ, Naidoo DP, Esterhuizen TM.
    Cardiovasc J S Afr; 2006 Dec 15; 17(2):60-6. PubMed ID: 16733598
    [Abstract] [Full Text] [Related]

  • 9. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, Wu H, Bai J.
    Clin Interv Aging; 2016 Dec 15; 11():245-53. PubMed ID: 27013868
    [Abstract] [Full Text] [Related]

  • 10. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D, Koenig W, Brenner H.
    Arch Intern Med; 2016 Dec 15; 166(22):2455-60. PubMed ID: 17159010
    [Abstract] [Full Text] [Related]

  • 11. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study.
    Mishra RK, Judson G, Christenson RH, DeFilippi C, Wu AHB, Whooley MA.
    Cardiology; 2017 Dec 15; 137(4):201-206. PubMed ID: 28445886
    [Abstract] [Full Text] [Related]

  • 12. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Daniels LB, Clopton P, deFilippi CR, Sanchez OA, Bahrami H, Lima JA, Tracy RP, Siscovick D, Bertoni AG, Greenland P, Cushman M, Maisel AS, Criqui MH.
    Am Heart J; 2015 Dec 15; 170(6):1170-83. PubMed ID: 26678639
    [Abstract] [Full Text] [Related]

  • 13. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
    Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E.
    J Am Coll Cardiol; 2008 Aug 05; 52(6):450-9. PubMed ID: 18672166
    [Abstract] [Full Text] [Related]

  • 14. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S, Sugiyama S.
    Intern Med; 2018 Sep 15; 57(18):2621-2630. PubMed ID: 29709934
    [Abstract] [Full Text] [Related]

  • 15. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemöller K, von Beckerath N, von Beckerath O, Vogt W, Schömig A.
    Am J Med; 2006 Apr 15; 119(4):355.e1-8. PubMed ID: 16564781
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.
    Atherosclerosis; 2013 Jun 15; 228(2):478-84. PubMed ID: 23582589
    [Abstract] [Full Text] [Related]

  • 17. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M, Bhatt DL, Vaduganathan M, Biering-Sørensen T, Qamar A, Diederichsen AC, Møller JE, Hindersson P, Leósdóttir M, Magnusson M, Nilsson PM, Olsen MH.
    Eur J Prev Cardiol; 2017 Oct 15; 24(15):1648-1659. PubMed ID: 28644092
    [Abstract] [Full Text] [Related]

  • 18. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E, Claggett B, Pfeffer MA, Diaz R, Dickstein K, Gerstein HC, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Køber L.
    J Am Heart Assoc; 2017 May 29; 6(6):. PubMed ID: 28554908
    [Abstract] [Full Text] [Related]

  • 19. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events　- The Japan Morning Surge-Home Blood Pressure Study.
    Taki M, Ishiyama Y, Mizuno H, Komori T, Kono K, Hoshide S, Kario K.
    Circ J; 2018 Jul 25; 82(8):2096-2102. PubMed ID: 29925742
    [Abstract] [Full Text] [Related]

  • 20. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.
    Mishra RK, Beatty AL, Jaganath R, Regan M, Wu AH, Whooley MA.
    J Am Heart Assoc; 2014 Jul 22; 3(4):. PubMed ID: 25053234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.